CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project aims to develop a novel immunoassay using protein microarrays to identify antibodies against Plasmodium falciparum, the malaria-causing parasite. By analyzing the immune responses of individuals in malaria-endemic areas, the project seeks to uncover protective antigens that could inform vaccine development…
People living in malaria endemic areas develop, with time, a form of immunity to infection and clinical disease mediated by antibodies directed against P. falciparum antigens.
Currently there are no assays or clinical parameters that predict whether an exposed person is protected against malaria.
This represents a major obstacle for vaccine development.
Here research institutions and industrial partners, combining cutting edge expertise in protein microarrays, immunoassay development, immunology…
UNIVERSITA DEGLI STUDI DI PERUGIA
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
United Kingdom, LONDON
Type: SME
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
SME: Yes
France, GRENOBLE
Type: Company (for-profit)
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
United Kingdom, London
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
